Cargando…
Aberrant Signaling Pathways in Glioma
Glioblastoma multiforme (GBM), a WHO grade IV malignant glioma, is the most common and lethal primary brain tumor in adults; few treatments are available. Median survival rates range from 12–15 months. The biological characteristics of this tumor are exemplified by prominent proliferation, active in...
Autores principales: | Nakada, Mitsutoshi, Kita, Daisuke, Watanabe, Takuya, Hayashi, Yutaka, Teng, Lei, Pyko, Ilya V., Hamada, Jun-Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759196/ https://www.ncbi.nlm.nih.gov/pubmed/24212955 http://dx.doi.org/10.3390/cancers3033242 |
Ejemplares similares
-
The strategy for enhancing temozolomide against malignant glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2012) -
Progressive tentorial cavernous malformation
por: Furuta, Takuya, et al.
Publicado: (2012) -
Orbital Cystic Schwannoma Originating from the Frontal Nerve
por: Hayashi, Yasuhiko, et al.
Publicado: (2012) -
Symptomatic foramen of Magendie arachnoid cyst in an elderly patient
por: Hayashi, Yasuhiko, et al.
Publicado: (2015) -
Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy
por: Domoto, Takahiro, et al.
Publicado: (2016)